Stoke Therapeutics Inc (NASDAQ:STOK)

12.02
Delayed Data
As of May 27
 +0.46 / +3.98%
Today’s Change
11.10
Today|||52-Week Range
41.60
-49.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2018
Quarter 1
2019

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization32.0K80.0K----
 
 
 
 
Operating ExpensesGross Income-32.0K-80.0K----
 
 
 
General Expenses1.9M6.2M----
 
 
 
Research And Development1.2M4.1M----
 
 
 
Total Operating Expenses1.9M6.3M----
 
 
 
 
Non-Operating ExpensesOperating Income-1.9M-6.3M----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-5.7M----
 
 
 
Net Income-1.9M-5.7M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.3M31.3M----
 
 
 
Shares To Calculate EPS Diluted31.3M31.3M----
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.18----
 
 
 
EPS Diluted-$0.06-$0.18----